Hardcover. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Paperback. Condizione: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Da: Lucky's Textbooks, Dallas, TX, U.S.A.
Condizione: New.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. 1 edition NO-PA16APR2015-KAP.
Da: Majestic Books, Hounslow, Regno Unito
EUR 66,13
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 62,54
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 65,15
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 69,40
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New.
Editore: Chapman and Hall/CRC 2021-03-31, 2021
ISBN 10: 0367727072 ISBN 13: 9780367727079
Lingua: Inglese
Da: Chiron Media, Wallingford, Regno Unito
EUR 68,59
Quantità: 10 disponibili
Aggiungi al carrelloPaperback. Condizione: New.
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 77,33
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 77,32
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: New.
Editore: Chapman and Hall/CRC 2019-06-28, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Lingua: Inglese
Da: Chiron Media, Wallingford, Regno Unito
EUR 76,96
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: New.
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 87,28
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Da: Revaluation Books, Exeter, Regno Unito
EUR 94,98
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 442 pages. 9.21x6.14x1.10 inches. In Stock.
Editore: Taylor and Francis Inc, US, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Lingua: Inglese
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 121,12
Quantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: New. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
Editore: LAP LAMBERT Academic Publishing, 2013
ISBN 10: 3659356573 ISBN 13: 9783659356575
Lingua: Inglese
Da: preigu, Osnabrück, Germania
EUR 58,00
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Debt Financing and Firm's Performance Decision | Analysis of Factors affecting the debt financing and the firm performance:Evidence of Non-Financial sector of Pakistan | Zahid Bashir | Taschenbuch | 184 S. | Englisch | 2013 | LAP LAMBERT Academic Publishing | EAN 9783659356575 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.
Editore: LAP LAMBERT Academic Publishing Feb 2013, 2013
ISBN 10: 3659356573 ISBN 13: 9783659356575
Lingua: Inglese
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 68,00
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Neuware -Debt financing decision is the most important and crucial decision in the study of capital structure and financial structure because it leads to firm¿s performance. The current Study empirically investigated a number of factors affecting debt financing decision and firm¿s performance for the non-financial companies listed in Karachi Stock Exchange of Pakistan for the period of 2005-2010. The financial theories like Tradeoff theory (TOT) and Packing order theory (POT) has also been tested in order to see the consistency of factors affecting the debt financing behavior in the current study with above said theories. A Panel data of 341 firms has been used for empirical analysis of the current Study. The variation in debt financing is measured by short-term, long term and total debt while the variation in firm¿s performance is measured by profitability and Return on Assets. The current study empirically examined the effect of firm¿s specific factors by econometric practice ¿one way-fixed effect regression model¿. The Current study will help the reader for understanding how the different factors affects debt financing and firm performance in non-financial sector of PakistanBooks on Demand GmbH, Überseering 33, 22297 Hamburg 184 pp. Englisch.
EUR 84,89
Quantità: 2 disponibili
Aggiungi al carrelloCondizione: New.
Da: Lucky's Textbooks, Dallas, TX, U.S.A.
EUR 140,93
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Editore: LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3848489538 ISBN 13: 9783848489534
Lingua: Inglese
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 128,84
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: Majestic Books, Hounslow, Regno Unito
EUR 151,73
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Condizione: New.
Editore: LAP LAMBERT Academic Publishing, 2013
ISBN 10: 3659356573 ISBN 13: 9783659356575
Lingua: Inglese
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 142,90
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 168,30
Quantità: 3 disponibili
Aggiungi al carrelloCondizione: New.
Editore: Taylor and Francis Inc, US, 2019
ISBN 10: 1498761305 ISBN 13: 9781498761307
Lingua: Inglese
Da: Rarewaves.com UK, London, Regno Unito
EUR 109,18
Quantità: 1 disponibili
Aggiungi al carrelloHardback. Condizione: New. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 166,32
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: New. New. Ships from Multiple Locations. book.